Jeff Yass’s Aktis Oncology AKTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,623
Closed -$210K – 15045
2026
Q2
$278K Buy
+8,623
New +$177K ﹤0.01% 11224

Other funds holding AKTS

Jeff Yass's AKTS Position: Q3 2026 in Review

Jeff Yass sold out of Aktis Oncology (AKTS) in Q3 2026, closing a stake of 8,623 shares — an estimated $210K sold.

Jeff Yass first reported a position in AKTS in Q2 2026 and held it in 1 quarter. The position peaked at $278K in Q2 2026. 108 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • Jeff Yass reported no remaining Aktis Oncology position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 8,623 Aktis Oncology shares in Q3 2026, an estimated $210K.
  • Jeff Yass first reported a position in Aktis Oncology in Q2 2026 and held it in 1 quarter.
  • Jeff Yass's Aktis Oncology position peaked at $278K in Q2 2026.
  • 108 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.